Phenmetetrazine
| Phenmetetrazine | |
|---|---|
| Molecular structure via molpic based on CDK |
| Physical properties [] | |
|---|---|
| Molecular mass | 205.30 g/mol [1] |
| Predicted LogP | 2.2 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C13H19NO [1] |
| IUPAC name | 4-ethyl-3-methyl-2-phenylmorpholine [1] |
| SMILES | CCN1CCOC(C1C)C2=CC=CC=C2 [1] |
| InChI | InChI=1S/C13H19NO/c1-3-14-9-10-15-13(11(14)2)12-7-5-4-6-8-12/h4-8,11,13H,3,9-10H2,1-2H3 [1] |
| InChIKey | ZOMTUQAEMGCZPK-UHFFFAOYSA-N [1] |
Phenmetetrazine (also known as N-Ethylphenmetrazine, 4-Ethyl-3-methyl-2-phenyl-morpholine, Morpholine, 4-ethyl-3-methyl-2-phenyl-, Unii-6qlt9858qu, Phenmetetrazine, Schembl10123770 or Dtxsid501342628) is a
Chemistry
Stereochemistry []
Phenmetetrazine is a racemic mixture of the diastereomers.
| Stereoisomerism |
|---|
| Stereoisomer enumberation with rdkit |
Subjective effects []
See also []
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 14425810, N-Ethylphenmetrazine. Accessed April 11, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/14425810
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Phenmetetrazine. UNII: 6QLT9858QU. Global Substance Registration System. Accessed April 11, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/6QLT9858QU